| Product Code: ETC7172308 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Fiji`s clinical oncology sector continued to rely on imports of next-generation sequencing technology, with top exporters being Australia, New Zealand, India, Bangladesh, and the USA. The market remained highly concentrated, indicating limited diversification in import sources. Despite a slight decline in growth rate from 2023 to 2024, the sector still saw a steady compound annual growth rate of 4.6% from 2020 to 2024. Fiji`s ongoing dependence on key exporting countries underscores the importance of strategic partnerships in meeting the country`s clinical oncology needs.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Fiji Clinical Oncology Next Generation Sequencing Market Overview |
3.1 Fiji Country Macro Economic Indicators |
3.2 Fiji Clinical Oncology Next Generation Sequencing Market Revenues & Volume, 2021 & 2031F |
3.3 Fiji Clinical Oncology Next Generation Sequencing Market - Industry Life Cycle |
3.4 Fiji Clinical Oncology Next Generation Sequencing Market - Porter's Five Forces |
3.5 Fiji Clinical Oncology Next Generation Sequencing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Fiji Clinical Oncology Next Generation Sequencing Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
3.7 Fiji Clinical Oncology Next Generation Sequencing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Fiji Clinical Oncology Next Generation Sequencing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Fiji Clinical Oncology Next Generation Sequencing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Fiji |
4.2.2 Growing adoption of precision medicine in oncology |
4.2.3 Technological advancements in next generation sequencing for clinical oncology |
4.3 Market Restraints |
4.3.1 High costs associated with next generation sequencing |
4.3.2 Limited awareness and expertise in utilizing next generation sequencing in clinical oncology in Fiji |
5 Fiji Clinical Oncology Next Generation Sequencing Market Trends |
6 Fiji Clinical Oncology Next Generation Sequencing Market, By Types |
6.1 Fiji Clinical Oncology Next Generation Sequencing Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Fiji Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Fiji Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Fiji Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 Fiji Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Targeted Sequencing, 2021- 2031F |
6.1.6 Fiji Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Resequencing, 2021- 2031F |
6.2 Fiji Clinical Oncology Next Generation Sequencing Market, By Workflow |
6.2.1 Overview and Analysis |
6.2.2 Fiji Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By NGS Pre-Sequencing, 2021- 2031F |
6.2.3 Fiji Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By NGS Sequencing, 2021- 2031F |
6.2.4 Fiji Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By NGS Data Analysis, 2021- 2031F |
6.3 Fiji Clinical Oncology Next Generation Sequencing Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Fiji Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Screening, 2021- 2031F |
6.3.3 Fiji Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Companion Diagnostics, 2021- 2031F |
6.3.4 Fiji Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Fiji Clinical Oncology Next Generation Sequencing Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Fiji Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Fiji Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Fiji Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Laboratories, 2021- 2031F |
6.4.5 Fiji Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Others, 2021- 2031F |
7 Fiji Clinical Oncology Next Generation Sequencing Market Import-Export Trade Statistics |
7.1 Fiji Clinical Oncology Next Generation Sequencing Market Export to Major Countries |
7.2 Fiji Clinical Oncology Next Generation Sequencing Market Imports from Major Countries |
8 Fiji Clinical Oncology Next Generation Sequencing Market Key Performance Indicators |
8.1 Average turnaround time for next generation sequencing tests |
8.2 Number of oncology centers offering next generation sequencing services |
8.3 Rate of adoption of next generation sequencing in clinical practice |
9 Fiji Clinical Oncology Next Generation Sequencing Market - Opportunity Assessment |
9.1 Fiji Clinical Oncology Next Generation Sequencing Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Fiji Clinical Oncology Next Generation Sequencing Market Opportunity Assessment, By Workflow, 2021 & 2031F |
9.3 Fiji Clinical Oncology Next Generation Sequencing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Fiji Clinical Oncology Next Generation Sequencing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Fiji Clinical Oncology Next Generation Sequencing Market - Competitive Landscape |
10.1 Fiji Clinical Oncology Next Generation Sequencing Market Revenue Share, By Companies, 2024 |
10.2 Fiji Clinical Oncology Next Generation Sequencing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |